Michael C. Zogby, partner and deputy practice leader of the Product Liability & Mass Torts group, participated in a panel discussion on the “Latest Developments in Electronic Discovery” during the Pharmaceutical Compliance Forum’s Annual Pharmaceutical and Medical Device Ethics and Complaisance Congress on November 3, 2021. Edward Glynn, principal of EY, moderated the panel, which also included Jeffrey Salling, Global Director of eDiscovery at Novartis, and Jennifer Joyce, senior manager at EY.
The speakers discussed:
- E-discovery in the midst of a global pandemic
- Changes in data collection, transfers and processes
- Enterprise systems
- Ephemeral data
- Considerations for pharmaceutical and medical device compliance teams
- Data protection and privacy
- Trial, litigation and mass tort considerations
Mike has significant experience defending major pharmaceutical, medical device, life sciences, biotechnology and chemical companies in product liability actions filed by consumer and government parties. He counsels clients in the United States, Asia and Europe on data privacy, governance and security, and crisis management, and he coordinates cross-border trial issues and discovery involving multidistrict proceedings and highly regulated industries. He is an elected member of the Products Liability Advisory Council and the International Association of Defense Counsel, a member of the Board of Directors for the Trial Attorneys of America and a Trustee of the Trial Attorneys of New Jersey. He is active in cross-border and discovery proportionality initiatives with the Sedona Conference and the James Humphrey Complex Litigation Center of the George Washington School of Law. Mike serves on the faculty of the National Trial Advocacy College at the University of Virginia School of Law, and has lectured on trial ethics for practitioners at Fordham University School of Law.